A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model
Actions
Order Assays
Multiple sclerosis (MS) involves the infiltration of autoreactive T cells into the CNS, yet we lack a comprehensive understanding of the signaling pathways that regulate this process. Here, we conducted a genome-wide in vivo CRISPR screen in a rat MS model and identified 5 essential brakes and 18 essential facilitators of T cell migration to the CNS. While the transcription factor ETS1 limits entry to the CNS by controlling T cell responsiveness, three functional modules, centered around the adhesion molecule α4-integrin, the chemokine receptor CXCR3 and the GRK2 kinase, are required for CNS migration of autoreactive CD4+ T cells. Single-cell analysis of T cells from individuals with MS confirmed that the expression of these essential regulators correlates with the propensity of CD4+ T cells to reach the CNS. Our data thus reveal key regulators of the fundamental step in the induction of MS lesions.
Export PNG
Creators and SubmitterViews: 23
Created: 6th Aug 2026 at 07:42
TagsThis item has not yet been tagged.
Related items
- People (2)
- Programmes (1)
- Projects (1)
- Investigations (1)
- Assays (3)
- Data files (3)
- Publications (1)
Projects: TRR 274: Checkpoints of Central Nervous System Recovery
Institutions: Universitätsmedizin Göttingen
Projects: CRC1002: Modulatory Units in Heart Failure, TRR 274: Checkpoints of Central Nervous System Recovery, SFB 1190: Compartmental Gates and Contact Sites in Cells
Web page: Not specified
https://rdp.sfb274.de/ (Research Data Platform) https://gepris.dfg.de/gepris/projekt/408885537 (DFG Gepris entry) The central nervous system (CNS) is a terminally differentiated tissue, where any insult carries a heightened risk - yet the tissue response to these insults is variable and can range from irreversible destruction to almost complete recovery. The rules that instruct these divergent outcomes are still unknown. The aim of this CRC is therefore to understand the biology of the multicellular ...
Programme: Sonderforschungsbereiche/Collaborative Research Centers
Public web page: https://www.sfb274.de/
In multiple sclerosis, an “energy crisis”, which entails axonal ATP depletion, contributes to neuronal dysfunction and ensuing neurodegeneration. We have identified dysregulation of the TCA cycle and specifically depletion of its pacemaker enzyme, IDH3, as a critical checkpoint of neuronal energy homeostasis. Targeting IDH3, however, leads only to partial reversal of axonal ATP deficits, pointing to further neuroenergetic checkpoints. We now plan to identify these checkpoints and study their ...
Submitter: Camilla Giudici
Studies: A genome-wide in vivo CRISPR screen identifies essential regulators of T..., Phagocyte-mediated synapse removal in cortical neuroinflammation is prom..., Targeting the TCA cycle can ameliorate widespread axonal energy deficien..., Twin study identifies early immunological and metabolic dysregulation of...
Assays: Expression profiling: Bulk RNA-seq (mouse), Expression profiling: Bulk RNA-seq (rat), Expression profiling: scRNA-seq (human), Expression profiling: scRNA-seq (human), Genome wide (GW) and validation CRISPR screens (rat), Shotgun proteomics (mouse)
Snapshots: No snapshots
Submitter: Camilla Giudici
Assay type: CRISPR Screen
Technology type: Technology Type
Investigation: C02 - In vivo detection and targeting of neuroe...
Organisms: Rat
SOPs: No SOPs
Data files: Genome wide (GW) and validation CRISPR screens ...
Snapshots: No snapshots
Submitter: Camilla Giudici
Assay type: Transcriptomics
Technology type: Sequencing
Investigation: C02 - In vivo detection and targeting of neuroe...
Organisms: Human
SOPs: No SOPs
Data files: scRNAseq of blood and CSF CD4+ T cells from MS ...
Snapshots: No snapshots
Submitter: Camilla Giudici
Assay type: Transcriptomics
Technology type: Sequencing
Investigation: C02 - In vivo detection and targeting of neuroe...
Organisms: Rat
SOPs: No SOPs
Data files: Effect of Grk2 (spleen, rat) or Ets1 (spleen an...
Snapshots: No snapshots
To study the effect of the Grk2 or Ets1 KOs in rat and human CD4+ T cells, in vivo or in vitro respectively, we generated KO CD4+ T cell lines by CRISPR-RNP nucleofection (with an gRNA targeting the gene locus) or control (with a non-targeting gRNA) 3' bulk RNAseq was conducted on CD4+ T-MBP rat cells isolated form spleen or spinal cord parenchyma three days after co-transfer of control and KO cells into the animal. Cells were FACS sorted based on their fluorescent protein reporters, BFP for ...
Creators: None
Submitter: Camilla Giudici
Investigations: C02 - In vivo detection and targeting of neuroe...
To study the regulation of candidate genes from our study in human cells, we analyzed CD4+ T cells from blood and CSF of MA patients and age and sex matched idiopathic intracranial hypertension controls We analyzed 40845 cells in control blood, 807 cells in control CSF, 29749 cells in MS blood and 15768 cells in MS CSF. Analysis of overlapping TCR sequences in blood and CSF CD4+ T cells of the same transcript, transcriptomic characterization of the cell clusters and analysis of the behaviour of ...
Creators: None
Submitter: Camilla Giudici
Investigations: C02 - In vivo detection and targeting of neuroe...
To identify genes driving encephalitogenic CD4+ T cell migration into the CNS, we performed a genome-wide CRISPR screen and a subsequent validation screen. For the genome-wide CRISPR screen, up to 4 sgRNA per gene and 800 non targeted controls were included, for a total of 87690 individual sgRNAs, and for the validation screen, up to 6 sgRNA per gene and 241 non targeted controls for a total of 12000 individual sgRNAs. Comparison of sgRNA distribution by pairwise comparisons across blood, spleen, ...
Creators: None
Submitter: Camilla Giudici
Abstract (Expand)
Authors: Arek Kendirli, Clara de la Rosa, Katrin F. Lämmle, Klara Eglseer, Isabel J. Bauer, Vladyslav Kavaka, Stephan Winklmeier, La Zhuo, Christian Wichmann, Lisa Ann Gerdes, Tania Kümpfel, Klaus Dornmair, Eduardo Beltrán, Martin Kerschensteiner, Naoto Kawakami
Date Published: 14th Sep 2023
Publication Type: Journal Article
DOI: 10.1038/s41593-023-01432-2
Citation: Nat Neurosci 26(10):1713-1725.
Download
https://orcid.org/0000-0003-4898-9383